Pulse height resolution of organic scintillators for monoenergeticgamma rays

The pulse height resolution of the NE102A and NE230 organic scintillators has been measured for monoenergetic gamma rays. The measurements were carried out the cylindrical NE102A scintillators and the NE230 scintillator using the gamma-gamma coincidence technique over the gamma-ray energy range 0.5-1.3 MeV. The energy resolution of the 125-mm NE102A detector varies from 22.8 to 13.3% over this energy range, while its energy corresponding to the half height of the Compton edge is 20.3 to 13.1% higher than the maximum energy of Compton electrons. Over the same energy range the energy resolution of the 50-mm NE102A detector varies from 19.6 to 11.5%, and its energy corresponding to the half height of the Compton edge is 12.6 to 6.6% higher than the maximum energy of Compton electrons. The energy resolution of the NE230 scintillator varies from 12.9 to 7.1% over this energy range, while its energy corresponding to the half height of the Compton edge is 10.4 to 2.1% higher than the maximum energy of Compton electron

Pulse height resolution of organic scintillators for monoenergeticgamma rays

The pulse height resolution of the NE102A and NE230 organic scintillators has been measured for monoenergetic gamma rays. The measurements were carried out the cylindrical NE102A scintillators and the NE230 scintillator using the gamma-gamma coincidence technique over the gamma-ray energy range 0.5-1.3 MeV. The energy resolution of the 125-mm NE102A detector varies from 22.8 to 13.3% over this energy range, while its energy corresponding to the half height of the Compton edge is 20.3 to 13.1% higher than the maximum energy of Compton electrons. Over the same energy range the energy resolution of the 50-mm NE102A detector varies from 19.6 to 11.5%, and its energy corresponding to the half height of the Compton edge is 12.6 to 6.6% higher than the maximum energy of Compton electrons. The energy resolution of the NE230 scintillator varies from 12.9 to 7.1% over this energy range, while its energy corresponding to the half height of the Compton edge is 10.4 to 2.1% higher than the maximum energy of Compton electron

Measurement of light output of NE213 and NE102A detectors for2.7-14.5 MeV neutrons

The light output of 125-mm-diameter NE213 and NE102A detectors has been measured for neutron energies ranging from 2.7 to 14.5 MeV. For neutron energies below 6.14 MeV, measurements were carried out using the neutron time-of-flight spectrum from an Am-Be neutron source, while for proton energies above 6.14 MeV, measurements were carried out using neutrons produced from the T(d,n) reaction. For the NE102A detector the measured light output is in good agreement with the data of R.A. Cecil et al., (1979) but for the NE213 detector the light output is 2-15% lower than that for a similar detector. The NE213 detector light output agrees with the data of V. Verbinski et al. (1968

Measurement of light output of NE213 and NE102A detectors for2.7-14.5 MeV neutrons

The light output of 125-mm-diameter NE213 and NE102A detectors has been measured for neutron energies ranging from 2.7 to 14.5 MeV. For neutron energies below 6.14 MeV, measurements were carried out using the neutron time-of-flight spectrum from an Am-Be neutron source, while for proton energies above 6.14 MeV, measurements were carried out using neutrons produced from the T(d,n) reaction. For the NE102A detector the measured light output is in good agreement with the data of R.A. Cecil et al., (1979) but for the NE213 detector the light output is 2-15% lower than that for a similar detector. The NE213 detector light output agrees with the data of V. Verbinski et al. (1968

Measurement of the Bottom-Strange Meson Mixing Phase in the Full CDF Data Set

We report a measurement of the bottom-strange meson mixing phase \beta_s using the time evolution of B0_s -> J/\psi (->\mu+\mu-) \phi (-> K+ K-) decays in which the quark-flavor content of the bottom-strange meson is identified at production. This measurement uses the full data set of proton-antiproton collisions at sqrt(s)= 1.96 TeV collected by the Collider Detector experiment at the Fermilab Tevatron, corresponding to 9.6 fb-1 of integrated luminosity. We report confidence regions in the two-dimensional space of \beta_s and the B0_s decay-width difference \Delta\Gamma_s, and measure \beta_s in [-\pi/2, -1.51] U [-0.06, 0.30] U [1.26, \pi/2] at the 68% confidence level, in agreement with the standard model expectation. Assuming the standard model value of \beta_s, we also determine \Delta\Gamma_s = 0.068 +- 0.026 (stat) +- 0.009 (syst) ps-1 and the mean B0_s lifetime, \tau_s = 1.528 +- 0.019 (stat) +- 0.009 (syst) ps, which are consistent and competitive with determinations by other experiments.Comment: 8 pages, 2 figures, Phys. Rev. Lett 109, 171802 (2012

Tracking development assistance for health and for COVID-19 : a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050

Background The rapid spread of COVID-19 renewed the focus on how health systems across the globe are financed, especially during public health emergencies. Development assistance is an important source of health financing in many low-income countries, yet little is known about how much of this funding was disbursed for COVID-19. We aimed to put development assistance for health for COVID-19 in the context of broader trends in global health financing, and to estimate total health spending from 1995 to 2050 and development assistance for COVID-19 in 2020. Methods We estimated domestic health spending and development assistance for health to generate total health-sector spending estimates for 204 countries and territories. We leveraged data from the WHO Global Health Expenditure Database to produce estimates of domestic health spending. To generate estimates for development assistance for health, we relied on project-level disbursement data from the major international development agencies' online databases and annual financial statements and reports for information on income sources. To adjust our estimates for 2020 to include disbursements related to COVID-19, we extracted project data on commitments and disbursements from a broader set of databases (because not all of the data sources used to estimate the historical series extend to 2020), including the UN Office of Humanitarian Assistance Financial Tracking Service and the International Aid Transparency Initiative. We reported all the historic and future spending estimates in inflation-adjusted 2020 US$, 2020 US$ per capita, purchasing-power parity-adjusted US$per capita, and as a proportion of gross domestic product. We used various models to generate future health spending to 2050. Findings In 2019, health spending globally reached$8. 8 trillion (95% uncertainty interval [UI] 8.7-8.8) or $1132 (1119-1143) per person. Spending on health varied within and across income groups and geographical regions. Of this total,$40.4 billion (0.5%, 95% UI 0.5-0.5) was development assistance for health provided to low-income and middle-income countries, which made up 24.6% (UI 24.0-25.1) of total spending in low-income countries. We estimate that $54.8 billion in development assistance for health was disbursed in 2020. Of this,$13.7 billion was targeted toward the COVID-19 health response. $12.3 billion was newly committed and$1.4 billion was repurposed from existing health projects. $3.1 billion (22.4$2.4 billion (17.9%) was for supply chain and logistics. Only $714.4 million (7.7$1519 (1448-1591) per person in 2050, although spending across countries is expected to remain varied. Interpretation Global health spending is expected to continue to grow, but remain unequally distributed between countries. We estimate that development organisations substantially increased the amount of development assistance for health provided in 2020. Continued efforts are needed to raise sufficient resources to mitigate the pandemic for the most vulnerable, and to help curtail the pandemic for all. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe

Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018

Anemia is a globally widespread condition in women and is associated with reduced economic productivity and increased mortality worldwide. Here we map annual 2000–2018 geospatial estimates of anemia prevalence in women of reproductive age (15–49 years) across 82 low- and middle-income countries (LMICs), stratify anemia by severity and aggregate results to policy-relevant administrative and national levels. Additionally, we provide subnational disparity analyses to provide a comprehensive overview of anemia prevalence inequalities within these countries and predict progress toward the World Health Organization’s Global Nutrition Target (WHO GNT) to reduce anemia by half by 2030. Our results demonstrate widespread moderate improvements in overall anemia prevalence but identify only three LMICs with a high probability of achieving the WHO GNT by 2030 at a national scale, and no LMIC is expected to achieve the target in all their subnational administrative units. Our maps show where large within-country disparities occur, as well as areas likely to fall short of the WHO GNT, offering precision public health tools so that adequate resource allocation and subsequent interventions can be targeted to the most vulnerable populations.Peer reviewe